GLP-1 Access & Economics
Explore peptide research and guides on glp-1 access & economics.
GLP-1 Access & Economics
Cost-Effectiveness of GLP-1s: Health Economics
ICER finds GLP-1s cost-effective at $53K-$69K per QALY but warns fewer than 1% of eligible patients can be treated at current prices.
GLP-1 Access & EconomicsGLP-1 Telehealth Prescribing: Online Clinics
Telehealth platforms now prescribe GLP-1s to millions. Data from 58,000+ patients shows real outcomes, but compounded drug risks and 60% dropout rates reveal the tradeoffs.